Globe Life Inc. (NYSE:GL – Get Free Report) CEO James Matthew Darden sold 9,527 shares of Globe Life stock in a transaction on Friday, February 27th. The shares were sold at an average price of $144.34, for a total value of $1,375,127.18. Following the completion of the transaction, the chief executive officer owned 53,860 shares in the company, valued at $7,774,152.40. The trade was a 15.03% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Globe Life Stock Performance
NYSE GL opened at $145.32 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life Inc. has a 1-year low of $109.38 and a 1-year high of $152.71. The firm has a market capitalization of $11.43 billion, a P/E ratio of 10.32 and a beta of 0.47. The business’s 50-day simple moving average is $141.88 and its 200-day simple moving average is $138.72.
Globe Life (NYSE:GL – Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period last year, the firm earned $3.14 earnings per share. The company’s quarterly revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.
Globe Life Increases Dividend
Wall Street Analysts Forecast Growth
GL has been the topic of a number of recent analyst reports. Truist Financial boosted their price objective on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Morgan Stanley reiterated an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research note on Monday, December 15th. Wells Fargo & Company boosted their price objective on shares of Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a research report on Wednesday. Evercore set a $157.00 target price on shares of Globe Life in a report on Wednesday, February 18th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $171.33.
Check Out Our Latest Stock Analysis on GL
Institutional Investors Weigh In On Globe Life
Several hedge funds and other institutional investors have recently bought and sold shares of GL. Vanguard Group Inc. grew its position in Globe Life by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after buying an additional 86,349 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Globe Life by 2.7% during the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after acquiring an additional 102,445 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Globe Life by 2.9% during the second quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock valued at $339,875,000 after purchasing an additional 76,995 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Globe Life by 2.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,135,861 shares of the company’s stock valued at $298,732,000 after purchasing an additional 59,629 shares during the period. Finally, Morgan Stanley increased its stake in Globe Life by 7.2% in the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock worth $260,176,000 after purchasing an additional 125,567 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.
Globe Life News Summary
Here are the key news stories impacting Globe Life this week:
- Positive Sentiment: Board raised the quarterly dividend to $0.33 (22.2% increase) and announced two new board members — supports income-focused investors and signals confidence in cash flow. GLOBE LIFE INC. DECLARES DIVIDEND AND ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
- Positive Sentiment: Wells Fargo published a positive price-forecast note on Globe Life, which can attract buyers and lend near-term support to the share price. Wells Fargo & Company Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price
- Neutral Sentiment: Globe Life Field booked for an Eagles concert, which forced a local high school to reschedule prom — shows strong event demand and venue utilization but has minimal direct impact on insurance operations. Eagles concert at Globe Life Field moves Texas high school’s prom night date How an Eagles concert at Globe Life Field bumped a North Texas high school prom
- Neutral Sentiment: GL was included in a Zacks piece highlighting high-ROE stocks as resilient plays; such coverage may raise investor interest but is not a company-specific catalyst. Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
- Negative Sentiment: CEO James Matthew Darden sold 9,527 shares (~15% reduction in his reported ownership), a sizable insider sale that can spook some investors. SEC Form 4 – Darden sale
- Negative Sentiment: EVP Robert Edward Hensley sold 712 shares (~7.7% reduction in his holding), another insider sale that adds to selling pressure signals. SEC Form 4 – Hensley sale
- Negative Sentiment: TipRanks flagged Globe Life’s rising allocation to alternative assets as increasing volatility, capital strain and liquidity risk — a potential medium-term headwind for valuation if realized. Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Articles
- Five stocks we like better than Globe Life
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
